Comment: Patient Focused Drug Development: Methodologic and Other Challenges Related to Patient Experience Data
Submitted to the Food and Drug Administration and Department of Health and Human Services
Policy
Comment: Insurance Coverage for Over-the-Counter Preventive Services Without a Prescription
Submitted to U.S. Departments of the Treasury, Labor, and Health and Human Services
Print:
On December 1, 2023, the LDI Maternal and Reproductive Health Working Group submitted a public comment in response to a Request for Information (RFI) from the U.S. Departments of the Treasury, Labor, and Health and Human Services. The RFI sought input on a proposed policy which would require insurance coverage of over-the-counter (OTC) preventive items and services without a prescription by a health care provider.
The comment highlights the obstacles that many patients, especially those from marginalized communities, face in accessing affordable birth control, and expresses the importance of and mechanisms for ensuring that OTC contraceptives are available without financial or logistical barriers.
More on Policy at LDI
Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren
Briefing: Health Impacts of Tax Incentives for Low-Income Families
Presented to Members of the Pennsylvania General Assembly and Governor Shapiro’s Office
Testimony: Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and Treatment
Delivered to the United States Senate Committee on Finance
Comment: Development of a Universal Symbol for Language Assistance Services in Health Settings
Submitted to the Office of Minority Health, U.S. Department of Health and Human Services
Comment: Health Care Market Consolidation and Private Equity Funds
Submitted to U.S. Department of Justice, Department of Health and Human Services, and Federal Trade Commission